Although approved in many other countries around the world such as the United States, Argentina, England, Japan, and Australia, ¹⁸F-Fluorodeoxyglucose (¹⁸F-FDG), the radiotracer most commonly used in PET/CT scanning, has not been widely approved for routine clinical use in Canada. As such, PET/CT scans performed at the BC Cancer Agency on adult and pediatric cancer patients are done under separate Clinical Trial Agreements with Health Canada.

The main purpose of each clinical trial is to evaluate the efficacy of ¹⁸F-FDG as manufactured by the BC Cancer Agency for use in patients undergoing scanning at our facility. Although ¹⁸F-FDG is considered investigational, it is also considered very safe and has been used in research settings at various centres in Canada for the past several years.

Below are printable patient consent forms for PET/CT scans to be done only at the BC Cancer Agency. All patients (or parents/guardians of pediatric patients) undergoing PET/CT scanning at our facility will need to sign the appropriate form before the scan can be performed.

It is not necessary for the patient to sign this form immediately as it is provided on this website for informational and preview purposes only. All patients will have the opportunity to ask our staff questions upon arrival to Functional Imaging prior to providing consent.
 

View/Download Adult Consent Form

View/Download Pediatric Consent Form 


Note: Adobe Acrobat Reader is required to view this document. To download a copy, click HERE.